do you have to stay on glp 1 forever GLP-1 Drugs For Effective Weight Control? Were you told you’d need
Description
telehealth GLP-1 programs
Participants reported greater BMI loss using tirzepatide compared with semaglutide (median 4.75 versus 3.71 kg m 2

Why Is the FDA Making This Change
Medical Conditions That May Exclude Candidacy Personal or family history of medullary thyroid carcinoma Multiple endocrine neoplasia type two Severe gastrointestinal conditions such as gastroparesis History of pancreatitis Active gallbladder disease Uncontrolled thyroid disease Severe renal impairment Situations That Require Special Caution Active eating disorders Pregnancy or breastfeeding Significant psychiatric concerns Low appetite baseline Medication Conflicts Insulin regimens Sulfonylureas Chronic steroid therapy Geneva evaluates all interactions carefully before prescribing
These early exits from therapy not only undermine clinical outcomes but also distort commercial forecasts and ROI projections

The timeline varies depending on the specific medication's half-lifeshorter-acting agents like liraglutide (half-life approximately 13 hours) clear more quickly than longer-acting options like semaglutide (half-life approximately one week)